Epigenetic Clocks Show Biological Age at Cell-Type Resolution
Biological age refers to how old a person’s body is biologically, which may differ from their actual age in years.
Related Articles
Science Visuals team picks its favorite stories of the year
Team members describe what went into making and publishing 2024’s most engaging images and multimedia
Competitive social feedback amplifies the role of early life contingency in male mice
Contingency (or “luck”) in early life plays an important role in shaping individuals’ development. By comparing the developmental trajectories of functionally genetically identical free-living mice…
The science stories likely to make the biggest headlines in 2025
Trump’s shakeups, risks from avian flu, and peak carbon emissions could produce big stories
Breathing polluted air increases risk of osteoporosis, growing evidence shows
Pollutants can interfere with bone growth in numerous ways, studies suggest
COVID 5 years later: Learning from a pandemic many are forgetting
Five years after SARS-CoV-2 surfaced, scientists reflect and look ahead to the next threat
A photoluminescent hydrogen-bonded biomass aerogel for sustainable radiative cooling
Passive radiant cooling is a potentially sustainable thermal management strategy amid escalating global climate change. However, petrochemical-derived cooling materials often face efficiency challenges owing to…
Common virus may help protect skin against Sun damage
Beta human papillomavirus helps the immune system target mutated skin cells, a “provocative” mouse and human study suggests
Preprints often make news. Many people don’t know what they are
The public needs context about unreviewed manuscripts, survey suggests
Accelerating Bispecific Antibody Discovery: From Antigens to Lead Panels in Just Four Months
Rapid Bispecific Discovery and the B-Body Bispecific Platform de-risk and accelerate antibody therapeutics.
NeueHealth to become a private company after $1.3B acquisition
The company was acquired by an affiliate of New Enterprise Associates and a consortium of investors for $1.3 billion.
